Galena Biopharma (GALE) Announces Enrollment Expansion of NeuVax Combo Phase 2b
Tweet Send to a Friend
Galena Biopharma (Nasdaq: GALE) announced that human leukocyte antigen (HLA) - A24+ or HLA-A26+ women are now eligible for enrollment ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
